BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22253543)

  • 1. Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes.
    Udensi UK; Graham-Evans BE; Rogers C; Isokpehi RD
    Clin Cosmet Investig Dermatol; 2011; 4():183-90. PubMed ID: 22253543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.
    Udensi UK; Cohly HH; Graham-Evans BE; Ndebele K; Garcia-Reyero N; Nanduri B; Tchounwou PB; Isokpehi RD
    Biomark Insights; 2011 Feb; 6():7-16. PubMed ID: 21461292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide.
    Udensi UK; Tackett AJ; Byrum S; Avaritt NL; Sengupta D; Moreland LW; Tchounwou PB; Isokpehi RD
    J Proteomics Bioinform; 2014 Jul; 7(7):166-178. PubMed ID: 25419056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings.
    Liu ZM; Tseng HY; Yeh BW; Wu WJ; Huang HS
    Arch Toxicol; 2015 Dec; 89(12):2229-41. PubMed ID: 25537191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic-induced genotoxic and cytotoxic effects in human keratinocytes, melanocytes and dendritic cells.
    Graham-Evans B; Cohly HH; Yu H; Tchounwou PB
    Int J Environ Res Public Health; 2004 Sep; 1(2):83-9. PubMed ID: 16696182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study.
    Fidrus E; Hegedűs C; Janka EA; Paragh G; Emri G; Remenyik É
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide, arsenic pentoxide, and arsenic iodide inhibit human keratinocyte proliferation through the induction of apoptosis.
    Tse WP; Cheng CH; Che CT; Lin ZX
    J Pharmacol Exp Ther; 2008 Aug; 326(2):388-94. PubMed ID: 18451318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
    Bi X; Gu J; Guo Z; Tao S; Wang Y; Tang L; Wu J; Mi Q
    Skin Pharmacol Physiol; 2010; 23(2):68-78. PubMed ID: 20016248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells.
    Alarifi S; Ali D; Alkahtani S; Siddiqui MA; Ali BA
    Onco Targets Ther; 2013; 6():75-84. PubMed ID: 23404534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.
    Weinmuellner R; Kryeziu K; Zbiral B; Tav K; Schoenhacker-Alte B; Groza D; Wimmer L; Schosserer M; Nagelreiter F; Rösinger S; Mildner M; Tschachler E; Grusch M; Grillari J; Heffeter P
    Arch Toxicol; 2018 Jan; 92(1):181-194. PubMed ID: 28776197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin enhancement of arsenic-induced apoptosis via stimulating ROS-dependent p53 protein ubiquitination in human HaCaT keratinocytes.
    Shen SC; Lee WR; Yang LY; Tsai HH; Yang LL; Chen YC
    Exp Dermatol; 2012 May; 21(5):370-5. PubMed ID: 22509835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids inhibit chronically exposed arsenic-induced proliferation and malignant transformation of HaCaT cells.
    Rajput M; Kujur PK; Mishra A; Singh RP
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):91-101. PubMed ID: 29049844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arotinoid trometamol inhibits arsenic trioxide-stimulated keratinocyte proliferation via the Wnt, Shh, and bone morphogenetic protein signaling pathways.
    Zhou X; Yan L; Bu XL; Xu XG; Bi XL; Gu J
    J Biol Regul Homeost Agents; 2019; 33(3):731-743. PubMed ID: 31232011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide.
    Sasaki A; Oshima Y; Fujimura A
    Exp Hematol; 2007 Feb; 35(2):252-62. PubMed ID: 17258074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2).
    Tchounwou PB; Wilson BA; Ishaque AB; Schneider J
    Mol Cell Biochem; 2001 Jun; 222(1-2):49-59. PubMed ID: 11678611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide Modulates DNA Synthesis and Apoptosis in Lung Carcinoma Cells.
    Walker AM; Stevens JJ; Tchounwou PB
    Met Ions Biol Med; 2010 May; 7(5):1996-2007. PubMed ID: 20454603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes.
    Zhao R; Hou Y; Xue P; Woods CG; Fu J; Feng B; Guan D; Sun G; Chan JY; Waalkes MP; Andersen ME; Pi J
    Environ Health Perspect; 2011 Jan; 119(1):56-62. PubMed ID: 20805060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmentally relevant concentration of arsenic trioxide and humic acid promoted tumor progression of human cervical cancer cells: In vivo and in vitro studies.
    Tsai ML; Yen CC; Lu FJ; Ting HC; Chang HR
    Environ Toxicol; 2016 Sep; 31(9):1121-32. PubMed ID: 25728215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and oxidative stress in human liver carcinoma cells exposed to arsenic trioxide (HepG(2)).
    Brown E; Yedjou CG; Tchounwou PB
    Met Ions Biol Med; 2008; 10():583-587. PubMed ID: 20657712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes.
    Bae DS; Gennings C; Carter WH; Yang RS; Campain JA
    Toxicol Sci; 2001 Sep; 63(1):132-42. PubMed ID: 11509753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.